Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules

[1]  Gurpreet Kaur Bhatia,et al.  Computational Purposing Phytochemicals against Cysteine Protease of Monkeypox Virus: An In-silico Approach , 2022, Journal of Pure and Applied Microbiology.

[2]  H. Harapan,et al.  Conspiratorial Attitude of the General Public in Jordan towards Emerging Virus Infections: A Cross-Sectional Study Amid the 2022 Monkeypox Outbreak , 2022, Tropical medicine and infectious disease.

[3]  A. Rabaan,et al.  Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies , 2022, Journal of medical virology.

[4]  R. P. Vivek-Ananth,et al.  In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs , 2022, Molecular Diversity.

[5]  A. Yassein,et al.  Biochemical and histopathological alterations induced by subchronic exposure to zinc oxide nanoparticle in male rats and assessment of its genotoxicicty , 2022, Journal of Umm Al-Qura University for Applied Sciences.

[6]  Z. Memish,et al.  Monkeypox: Immune response, vaccination and preventive efforts , 2022, Narra J.

[7]  Sameer H Qari,et al.  Anti-aging trait of whey protein against brain damage of senile rats , 2022, Journal of Umm Al-Qura University for Applied Sciences.

[8]  H. Harapan,et al.  Monkeypox: A Comprehensive Review , 2022, Viruses.

[9]  A. Rodríguez-Morales,et al.  The human monkeypox in Saudi Arabia and global tourism , 2022, Annals of medicine and surgery.

[10]  H. Harapan,et al.  Assessing Healthcare Workers’ Knowledge and Their Confidence in the Diagnosis and Management of Human Monkeypox: A Cross-Sectional Study in a Middle Eastern Country , 2022, Healthcare.

[11]  Mariam Alsanafi,et al.  Monkeypox Knowledge and Confidence in Diagnosis and Management with Evaluation of Emerging Virus Infection Conspiracies among Health Professionals in Kuwait , 2022, Pathogens.

[12]  J. Borges-Costa,et al.  Monkeypox infection and bacterial cellulitis: a complication to look for , 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  H. Gendelman,et al.  The 2022 outbreak and the pathobiology of the monkeypox virus , 2022, Journal of autoimmunity.

[14]  Jennifer L. Small,et al.  Clinical features and management of human monkeypox: a retrospective observational study in the UK , 2022, The Lancet. Infectious diseases.

[15]  Colin J. Carlson,et al.  Climate change increases cross-species viral transmission risk , 2022, Nature.

[16]  Rosamaria Pennisi,et al.  Antiviral Activity Exerted by Natural Products against Human Viruses , 2021, Viruses.

[17]  Ullrich K. H. Ecker,et al.  Toward effective government communication strategies in the era of COVID-19 , 2021 .

[18]  Najaf Allahyari Fard,et al.  Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease , 2021, Informatics in Medicine Unlocked.

[19]  P. Vijayaraghavan,et al.  Non-Pharmaceutical Interventions are Measures to Control Coronavirus Disease-2019 (COVID-19) Transmission in India , 2020, Coronaviruses.

[20]  N. Campillo,et al.  COVID-19: Drug Targets and Potential Treatments , 2020, Journal of medicinal chemistry.

[21]  T. Sell,et al.  Misinformation and the US Ebola communication crisis: analyzing the veracity and content of social media messages related to a fear-inducing infectious disease outbreak , 2020, BMC Public Health.

[22]  A. Mahafzah,et al.  Conspiracy Beliefs Are Associated with Lower Knowledge and Higher Anxiety Levels Regarding COVID-19 among Students at the University of Jordan , 2020, medRxiv.

[23]  H. Odhar,et al.  Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus , 2020, Bioinformation.

[24]  Alan Talevi,et al.  Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective , 2015, Front. Pharmacol..